4//SEC Filing
GALEN PARTNERS IV LP 4
Accession 0001209191-09-048027
CIK 0001254419other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 6:19 PM ET
Size
23.9 KB
Accession
0001209191-09-048027
Insider Transaction Report
Form 4
MEDASSETS INCMDAS
Transactions
- Sale
Common Stock
2009-10-06$22.06/sh−5,100$112,506→ 5,984,552 total(indirect: See footnotes) - Sale
Common Stock
2009-10-05$22.06/sh−4,947$109,131→ 5,989,652 total(indirect: See footnotes)
Transactions
- Sale
Common Stock
2009-10-05$22.06/sh−4,947$109,131→ 5,989,652 total(indirect: See footnotes) - Sale
Common Stock
2009-10-06$22.06/sh−5,100$112,506→ 5,984,552 total(indirect: See footnotes)
Transactions
- Sale
Common Stock
2009-10-05$22.06/sh−4,947$109,131→ 5,989,652 total(indirect: See footnotes) - Sale
Common Stock
2009-10-06$22.06/sh−5,100$112,506→ 5,984,552 total(indirect: See footnotes)
CLAUDIUS LLC
10% Owner
Transactions
- Sale
Common Stock
2009-10-06$22.06/sh−5,100$112,506→ 5,984,552 total(indirect: See footnotes) - Sale
Common Stock
2009-10-05$22.06/sh−4,947$109,131→ 5,989,652 total(indirect: See footnotes)
Transactions
- Sale
Common Stock
2009-10-05$22.06/sh−4,947$109,131→ 5,989,652 total(indirect: See footnotes) - Sale
Common Stock
2009-10-06$22.06/sh−5,100$112,506→ 5,984,552 total(indirect: See footnotes)
Transactions
- Sale
Common Stock
2009-10-06$22.06/sh−5,100$112,506→ 5,984,552 total(indirect: See footnotes) - Sale
Common Stock
2009-10-05$22.06/sh−4,947$109,131→ 5,989,652 total(indirect: See footnotes)
Transactions
- Sale
Common Stock
2009-10-06$22.06/sh−5,100$112,506→ 5,984,552 total(indirect: See footnotes) - Sale
Common Stock
2009-10-05$22.06/sh−4,947$109,131→ 5,989,652 total(indirect: See footnotes)
GALEN PARTNERS IV LP
Other
Transactions
- Sale
Common Stock
2009-10-06$22.06/sh−5,100$112,506→ 5,984,552 total(indirect: See footnotes) - Sale
Common Stock
2009-10-05$22.06/sh−4,947$109,131→ 5,989,652 total(indirect: See footnotes)
Claudius IV, LLC
Other
Transactions
- Sale
Common Stock
2009-10-05$22.06/sh−4,947$109,131→ 5,989,652 total(indirect: See footnotes) - Sale
Common Stock
2009-10-06$22.06/sh−5,100$112,506→ 5,984,552 total(indirect: See footnotes)
Footnotes (7)
- [F1]The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Funds on September 1, 2009.
- [F2]The shares were sold as follows: 870 by Galen Partners IV, L.P. ("Galen IV"), 69 shares by Galen Partners International IV, L.P. ("Galen International IV"), 1 share by Galen Employee Fund IV, L.P. ("Employee Fund IV"), 3,662 by Galen Partners III, L.P. ("Galen III"), 332 by Galen Partners International III, L.P. ("Galen International III") and 13 shares by Galen Employee Fund III, L.P. ("Employee Fund III" and, collectively with Galen IV, Galen International IV, Employee Fund IV, Galen III, Galen International III, the "Funds").
- [F3]The shares are held as follows: 1,045,017 by Galen IV, 83,011 by Galen International IV, 1,458 by Employee Fund IV, 4,397,729 by Galen III, 398,551 by Galen International III, 18,777 by Employee Fund III and 45,109 by Galen Investment Advisory Group, L.L.C. ("Galen Investment"). Claudius IV, L.L.C. serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.
- [F4]Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.
- [F5]The shares were sold as follows: 897 by Galen IV, 72 shares by Galen International IV, 1 share by Employee Fund IV, 3,775 by Galen III, 342 by Galen International III, and 13 shares by Employee Fund III.
- [F6]The shares are held as follows: 1,044,120 by Galen IV, 82,939 by Galen International IV, 1,457 by Employee Fund IV, 4,393,954 by Galen III, 398,209 by Galen International III, 18,764 by Employee Fund III and 45,109 by Galen Investment. Claudius IV, L.L.C. serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.
- [F7]Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.
Documents
Issuer
MEDASSETS INC
CIK 0001254419
Entity typeother
Related Parties
1- filerCIK 0001203341
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 6:19 PM ET
- Size
- 23.9 KB